We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PANEL PROPOSES LIMITS ON PHARMA CONSULTING BY NIH EMPLOYEES
PANEL PROPOSES LIMITS ON PHARMA CONSULTING BY NIH EMPLOYEES
May 10, 2004
A blue-ribbon panel established by NIH Director Elias Zerhouni has recommended that the National Institutes of Health's senior management employees and professional staff who manage grants not take consulting or speaking fees from drugmakers.